(Press-News.org) BOSTON––Findings from a nationwide study led by researchers at Dana-Farber Cancer Institute suggest that patients with advanced lung or colorectal cancer are frequently mistaken in their beliefs that chemotherapy can cure their disease.
The study, published in the Oct. 25 issue of the New England Journal of Medicine, found that 69 percent of patients with advanced lung cancer and 81 percent of patients with advanced colorectal cancer did not understand that the chemotherapy they were receiving was not at all likely to cure their disease. Their expectations run counter to the fact that although chemotherapy can alleviate pain and extend life in such patients by weeks or months, it is not a cure for these types of advanced cancer except in the rarest of circumstances.
The findings come from the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS), a large nationwide study sponsored by the National Cancer Institute to understand many facets of cancer care in the United States. The study's lead author is Jane Weeks, MD, MSc, who is the CanCORS Consortium's scientific chair and is director of the McGraw/Patterson Center for Population Sciences at Dana-Farber, professor of medicine at Harvard Medical School and Professor of Health Policy and Management at Harvard School of Public Health.
The study was conducted by surveying 1,274 patients at hospitals, clinics and treatment centers across the country and by undertaking comprehensive review of their records. Study participants had been diagnosed with metastatic lung or colorectal cancer at least four months earlier and had received chemotherapy for their disease.
While previous studies had polled cancer patients about their perceptions of chemotherapy, this was the first to involve such a large and varied cross-section of the population. The study revealed that inaccurate expectations about the role of chemotherapy were found among patients from varied backgrounds treated in many different health care settings across the U.S.
Weeks noted that "If patients do not know whether a treatment offers a realistic possibility of cure, their ability to make informed treatment decisions that are consistent with their preferences may be compromised. This misunderstanding may pose obstacles to optimal end-of-life planning."
Surprisingly, patients who rated their communication with their physician highly were the most likely to hold overoptimistic views about chemotherapy's curative potential. While there is no doubt that communication about prognosis in advanced cancer is challenging, a sizeable minority of study participants did grasp the incurable nature of their cancers. Study co-author Deborah Schrag, MD, MPH, said that "skilled clinicians can set realistic expectations without their patients' losing either hope or trust." However, further research will be necessary to identify strategies to help physicians more consistently set realistic expectations and thereby help patients make good decisions about their care.
INFORMATION:
Other study co-authors include Paul Catalano, ScD, Angel Cronin, and Jennifer Mack, MD, MPH, of Dana-Farber; Matthew Finkelman, PhD, of Tufts University; and Nancy Keating, MD, MPH, of Brigham and Women's Hospital.
The study was funded by grants from the National Cancer Institute (U01 CA093344, U01 CA093332, U01 CA093324, U01 CA093348, U01 CA093329, U01 CA093339, U01 CA093326) and by a grant from the Department of Veterans Affairs (CRS 02-164), which support a research consortium of eight grantees to measure the quality of cancer care and associated health outcomes in the U.S. CanCORS recruited approximately10,000 patients with newly diagnosed lung cancer or colorectal cancer. Participants were recruited from geographically diverse populations and health care systems in order to systematically evaluate cancer care delivery in the U.S.
Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It provides adult care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center, and it provides pediatric care with Boston Children's Hospital as Dana-Farber/Children's Hospital Cancer Center. Dana-Farber is the top-ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding. Follow Dana-Farber on Twitter: @dana-farber or Facebook: facebook.com/danafarbercancerinstitute.
Advanced cancer patients overoptimistic about chemotherapy's ability to cure, study finds
2012-10-25
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Future training in bystander CPR needs targeted approach in 'high-risk' neighborhoods
2012-10-25
Residents living in high-income white and high-income integrated neighborhoods were more likely to receive bystander CPR (cardiopulmonary resuscitation) during an out-of-hospital cardiac arrest than arrest victims in low-income black neighborhoods, according to a publication in the Oct. 25 issue of the New England Journal of Medicine (NEJM). Arrest victims in low-income white, low-income integrated and high-income black neighborhoods were also less likely to receive bystander CPR.
In an effort to look at future CPR training processes and public health planning, researchers ...
Prescription for palliative care: 4 points to improve discussions about dying
2012-10-25
In an editorial appearing in the October 25 issue of The New England Journal of Medicine, medical oncologists at Johns Hopkins and Brigham and Women's hospitals provide a four-point plan for integrating palliative care discussions throughout the treatment of patients with terminal illnesses. They write that better planning and communication may improve symptoms, stress, and survival time, as well as lower health care costs at the end of life.
The two physicians suggest that their colleagues should discuss palliative care with patients during initial talks about prognosis ...
Gaps in border controls are related to alien insect invasions in Europe
2012-10-25
European countries with gaps in border security surrounding agricultural imports have been invaded by the largest number of exotic insect pests, according to research published Oct 24 in the open access journal PLOS ONE by Steven Bacon and colleagues from the Swiss Federal Research Station Agroscope ART and the University of Fribourg, Switzerland.
Invasive agricultural pests pose growing environmental and economic problems, threatening biodiversity and costing billions of dollars in economic losses annually. Large volumes of cross-border trade increase the risks of invasion, ...
OHSU researchers test new gene therapy method in human cells... and it works
2012-10-25
PORTLAND, Ore. - Oregon Health & Science University's development of a new gene therapy method to prevent certain inherited diseases has reached a significant milestone. Researchers at the university's Oregon National Primate Research Center and the OHSU Department of Obstetrics & Gynecology have successfully demonstrated their procedure in human cells. It's believed that this research, along with other efforts, will pave the way for future clinical trials in human subjects.
The research results are online Wednesday, Oct. 24, in the highly respected journal Nature. Dr. ...
Archer fish hunt insects with water jet 6 times stronger than their muscular power
2012-10-25
Archer fish knock their insect prey out of overhanging vegetation with a jet of water several times more powerful than the fish's muscles. New research now shows that the fish generate this power externally using water dynamics rather than with any specialized internal organs. The research, published Oct. 24 in the open access journal PLOS ONE by Alberto Vailati and colleagues from the University of Milan, provides the first explanation for how archer fish can generate such powerful jets to capture their prey.
Other animals like chameleons and salamanders store energy ...
Older adults worse at distinguishing between lifted weights than younger counterparts
2012-10-25
As we grow older, we are less capable of correctly estimating differences in the weights of objects we lift, according to a study published Oct. 24 in the open access journal PLOS ONE by Jessica Holmin and Farley Norman from North Dakota State University and Western Kentucky University, respectively.
Previous studies have shown that aging is frequently associated with a decrease in muscle mass and consequently strength, making it more difficult to lift objects. As a result, older adults often perceive weights they lift as being heavier than they actually are. In the current ...
Satellite images tell tales of changing biodiversity
2012-10-25
Analysis of texture differences in satellite images may be an effective way to monitor changes in vegetation, soil and water patterns over time, with potential implications for measuring biodiversity as well, according to new research published Oct. 24 by Matteo Convertino from the University of Florida and colleagues in the open access journal PLOS ONE.
The authors designed statistical models to estimate two aspects of biodiversity in satellite images: the number of species in a given region, or 'species richness', and the rate at which species entered or were removed ...
Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy
2012-10-25
BOSTON—Aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation, Dana-Farber Cancer Institute scientists report in the Oct. 25 issue of the New England Journal of Medicine.
In a study involving more than 900 patients with colorectal cancer, the researchers found that, for patients whose tumors harbored a mutation in the gene PIK3CA, aspirin use produced a sharp jump in survival: five years after diagnosis, 97 percent of those taking aspirin were still alive, compared ...
Electronic nose could be used to detect sleep apnoea
2012-10-25
An electronic nose, used to detect the presence of molecules in the breath of a patient, could be used to diagnose obstructive sleep apnoea.
A new study, published online today ahead of print (25 October 2012) in the European Respiratory Journal, could make the diagnosis of the condition quick and inexpensive compared to current methods.
The gold standard used to identify sleep apnoea is an overnight sleep test. This is technically demanding, time-consuming and cost-intensive.
Electronic nose devices have been shown to distinguish between a number of diseases; ...
Live cables explain enigmatic electric currents
2012-10-25
This press release is available in German.
Researchers at Aarhus University, Denmark, made a sensational discovery almost three years ago when they measured electric currents in the seabed. It was unclear as to what was conducting the current, but the researchers imagined the electric currents might run between different bacteria via a joint external wiring network.The researchers have now solved the mystery. It turns out that the whole process takes place inside bacteria that are one centimetre long. They make up a kind of live electric cable that no one had ever imagined ...